Biotech | September 18, 2021
Excision receives U.S. FDA clearance for first-in-human CRISPR Phase I/II trail for HIV
Initiation of EBT-101 Phase 1/2 clinical trial expected later this year
Initiation of EBT-101 Phase 1/2 clinical trial expected later this year
Study to explore heterologous regimen of COVID-19 vaccines from different manufacturers in adolescents 12-16 years of age
The clinical trial, to be conducted in two phases, will evaluate the safety and efficacy of Mesocel for the treatment of patients with moderate to severe Covid-19
They enter into exclusive negotiations in a new drive to create a technology-driven leader for complex small molecules and ADCs of global scale
BB will have access to 100 million doses of vaccines annually and commercialization rights of the SILS vaccine portfolio for global markets
_256_384.jpg)
CLSA, a capital market and investment group organised an Investors’ Forum where five Indian pharma companies participated. Excerpts from the report
Barbara Engelhardt moves her computational and statistics lab to Gladstone
Klifovet’s client base comprises the world’s top animal health and nutrition companies as well as many promising startups
Godrej and Boyce and Isgec Engineering have confirmed receiving the orders
It approves tissue-based NGS companion diagnostic for Takeda's targeted therapy for NSCLC patients with EGFR Exon20 insertion mutations
Subscribe To Our Newsletter & Stay Updated
